Clinical Trial Update: A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of DU-176b for prevention of venous thromboembolism after total hip arthroplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Hip Arthroplasty-associated Vte
• Venous Thromboembolism

Drugs mentioned

• DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Prevention, Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2015-01-26